(Q31871319)

4 July 2017

1 reference

title

The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer (English)

1 reference

4 July 2017

0 references

1 reference

1 reference

Grossi F

1

1 reference

4 July 2017

Scolaro T

2

1 reference

4 July 2017

Tixi L

3

1 reference

4 July 2017

Loprevite M

4

1 reference

4 July 2017

Ardizzoni A

5

1 reference

4 July 2017

publication date

1 January 2001

1 reference

Critical Reviews in Oncology Hematology

4 July 2017

published in

1 reference

4 July 2017

volume

37

1 reference

4 July 2017

issue

1

1 reference

4 July 2017

page(s)

61-67

1 reference

CNS metastases in small cell bronchogenic carcinoma.Increasing frequency and changing pattern with lengthening survival

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

A randomized combined modality trial in small cell carcinoma of the lung comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Intracranial metastases in small cell carcinoma of the lung prognostic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Favorable prognosis of brain metastases in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Comparison of symptomatic and prophylactic irradiation of brain metastases from oat cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Results of therapeutic cranial irradiation in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Treatment of brain metastases of lung cancer with high doses of etoposide (VP16–213). Cooperative study from the groupe français pneumo-cancérologie

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

High dose etoposide for brain metastases of small cell lung cancer. A phase II study. The EORTC Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Brain metastases from small cell lung cancer treated with combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Primary chemotherapy of brain metastasis in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

The response of cerebral metastases in small cell lung cancer to systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Prospective evaluation of the effect on initial brain metastases from small cell lung cancer of platinum-etoposide based induction chemotherapy followed by an alternating multidrug regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Systemic chemotherapy of brain metastases from small-cell lung cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

The Effect of Steroids on the Extravascular Distribution of Radiographic Contrast Material and Technetium Pertechnetate in Brain Tumors as Determined by Computed Tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Chemotherapy for brain metastases of lung cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Topotecan--a new treatment option in the therapy of brain metastases of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

A randomized trial of surgery in the treatment of single metastases to the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900098-6

7 January 2021

10.1016/S1040-8428(00)00098-6

Identifiers

DOI

1 reference

4 July 2017

1 reference